ATE226446T1 - Muteine von wildtyp-cytokinen und ihre verwendung als immunogene - Google Patents
Muteine von wildtyp-cytokinen und ihre verwendung als immunogeneInfo
- Publication number
- ATE226446T1 ATE226446T1 AT96930345T AT96930345T ATE226446T1 AT E226446 T1 ATE226446 T1 AT E226446T1 AT 96930345 T AT96930345 T AT 96930345T AT 96930345 T AT96930345 T AT 96930345T AT E226446 T1 ATE226446 T1 AT E226446T1
- Authority
- AT
- Austria
- Prior art keywords
- cytokines
- muteins
- immunogens
- wild
- type cytokines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Noise Elimination (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95RM000589A IT1277926B1 (it) | 1995-09-01 | 1995-09-01 | Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire |
| PCT/IT1996/000164 WO1997009064A1 (en) | 1995-09-01 | 1996-08-22 | Use of muteins of wild-type cytokines as immunogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226446T1 true ATE226446T1 (de) | 2002-11-15 |
Family
ID=11403544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96930345T ATE226446T1 (de) | 1995-09-01 | 1996-08-22 | Muteine von wildtyp-cytokinen und ihre verwendung als immunogene |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6706261B1 (de) |
| EP (1) | EP0858345B1 (de) |
| JP (1) | JP3157837B2 (de) |
| KR (1) | KR100279539B1 (de) |
| CN (1) | CN1138562C (de) |
| AT (1) | ATE226446T1 (de) |
| AU (1) | AU703300B2 (de) |
| CA (1) | CA2229045C (de) |
| DE (1) | DE69624498T2 (de) |
| DK (1) | DK0858345T3 (de) |
| ES (1) | ES2183007T3 (de) |
| HK (1) | HK1015708A1 (de) |
| IT (1) | IT1277926B1 (de) |
| MX (1) | MX9801550A (de) |
| PT (1) | PT858345E (de) |
| RU (1) | RU2182014C2 (de) |
| WO (1) | WO1997009064A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7645700A (en) * | 1999-10-07 | 2001-05-10 | Maxygen Aps | Single-chain antagonist polypeptides |
| FR2812813B1 (fr) | 2000-08-09 | 2004-11-26 | Neovacs | Utilisation d'immunogenes pour traiter ou prevenir au sein des tumeurs malignes les dereglements immunitaires induits par des facteurs extracellulaires |
| IL161672A0 (en) * | 2004-04-29 | 2004-09-27 | Yeda Res & Dev | Compositions and methods for therapy of chemotherapy-induced neuropathy |
| FR2978964B1 (fr) | 2011-08-09 | 2015-02-20 | Conservatoire Nat Arts | Composition vaccinale anti-il-6 |
| WO2015024148A1 (zh) * | 2013-08-23 | 2015-02-26 | 中国科学院微生物研究所 | 异源动物细胞因子突变体疫苗 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2677654B1 (fr) | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv. |
| US5338833A (en) * | 1992-07-23 | 1994-08-16 | The University Of North Carolina At Chapel Hill | Carboxy terminal IL-6 muteins |
| IT1263022B (it) * | 1992-11-06 | 1996-07-23 | Angeletti P Ist Richerche Bio | Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica. |
| IT1261787B (it) * | 1993-06-23 | 1996-06-03 | Angeletti P Ist Richerche Bio | Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. |
| AU6961796A (en) | 1995-09-12 | 1997-04-01 | Chiron Corporation | Improved interleukin-6 receptor antagonist |
-
1995
- 1995-09-01 IT IT95RM000589A patent/IT1277926B1/it active IP Right Grant
-
1996
- 1996-08-22 DK DK96930345T patent/DK0858345T3/da active
- 1996-08-22 MX MX9801550A patent/MX9801550A/es not_active IP Right Cessation
- 1996-08-22 PT PT96930345T patent/PT858345E/pt unknown
- 1996-08-22 DE DE69624498T patent/DE69624498T2/de not_active Expired - Fee Related
- 1996-08-22 KR KR1019980701561A patent/KR100279539B1/ko not_active IP Right Cessation
- 1996-08-22 RU RU98105679/14A patent/RU2182014C2/ru not_active IP Right Cessation
- 1996-08-22 AU AU69428/96A patent/AU703300B2/en not_active Ceased
- 1996-08-22 AT AT96930345T patent/ATE226446T1/de not_active IP Right Cessation
- 1996-08-22 ES ES96930345T patent/ES2183007T3/es not_active Expired - Lifetime
- 1996-08-22 EP EP96930345A patent/EP0858345B1/de not_active Expired - Lifetime
- 1996-08-22 WO PCT/IT1996/000164 patent/WO1997009064A1/en active IP Right Grant
- 1996-08-22 CA CA002229045A patent/CA2229045C/en not_active Expired - Fee Related
- 1996-08-22 JP JP51104897A patent/JP3157837B2/ja not_active Expired - Fee Related
- 1996-08-22 CN CNB961972955A patent/CN1138562C/zh not_active Expired - Fee Related
-
1999
- 1999-03-09 HK HK99100962A patent/HK1015708A1/xx not_active IP Right Cessation
-
2000
- 2000-04-27 US US09/559,950 patent/US6706261B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100279539B1 (ko) | 2001-02-01 |
| CA2229045C (en) | 2005-10-25 |
| CN1198098A (zh) | 1998-11-04 |
| KR19990044321A (ko) | 1999-06-25 |
| CN1138562C (zh) | 2004-02-18 |
| PT858345E (pt) | 2003-02-28 |
| RU2182014C2 (ru) | 2002-05-10 |
| US6706261B1 (en) | 2004-03-16 |
| WO1997009064A1 (en) | 1997-03-13 |
| DE69624498D1 (de) | 2002-11-28 |
| IT1277926B1 (it) | 1997-11-12 |
| HK1015708A1 (en) | 1999-10-22 |
| JPH10511111A (ja) | 1998-10-27 |
| ES2183007T3 (es) | 2003-03-16 |
| CA2229045A1 (en) | 1997-03-13 |
| EP0858345A1 (de) | 1998-08-19 |
| AU6942896A (en) | 1997-03-27 |
| ITRM950589A0 (it) | 1995-09-01 |
| EP0858345B1 (de) | 2002-10-23 |
| DE69624498T2 (de) | 2003-06-18 |
| ITRM950589A1 (it) | 1997-03-01 |
| MX9801550A (es) | 1998-05-31 |
| AU703300B2 (en) | 1999-03-25 |
| JP3157837B2 (ja) | 2001-04-16 |
| DK0858345T3 (da) | 2003-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0591281T3 (da) | Immunogene forbindelser, der især har anticytokinvirkning, fremstillingsfremgangsmåde, farmaceutiske præparater samt kits, | |
| DE60332358D1 (de) | Protease-resistente modifizierte interferon alpha polypeptide | |
| ATE233738T1 (de) | Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten | |
| BRPI0508455A (pt) | muteìnas de interleucina-2 combinatórias | |
| ATE194608T1 (de) | 5-substituierte derivate von mycophenolsäure | |
| EP1043995A4 (de) | INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN | |
| ES2169127T3 (es) | Nuevos carbamatos y ureas como modificadores de la resistencia multi-farmaco. | |
| DE69826695D1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
| DE69731540D1 (de) | Behandlung von diarrhoe | |
| DE60136577D1 (de) | Fragmente des menschlichen Choriogonadotropin (hcg) als Immunregulator | |
| DK0689449T3 (da) | Præparater til anvendelse i humanterapi, kendetegnet ved kombination af et muramylpeptid med en cytokin | |
| TR199900318T2 (xx) | IL-8 resept�r antagonistleri. | |
| DK0851926T3 (da) | Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet | |
| DE69833937D1 (de) | Verwendung von zinkhyaluronat gegen magengeschwür | |
| ATE403714T1 (de) | Tumor necrosis factor rezeptor abspaltendes enzym,dessen zubereitungen und verwendungen | |
| PT1082131E (pt) | Imuno-regulador | |
| ATE226446T1 (de) | Muteine von wildtyp-cytokinen und ihre verwendung als immunogene | |
| DE69736276D1 (de) | Menschliche dnase resistent gegen actininhibitoren | |
| ES2058343T3 (es) | Piridinas disubstituidas. | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| ATE420951T1 (de) | Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen | |
| DE59406934D1 (de) | Neue verwendung von equisetum | |
| ATE94074T1 (de) | Verwendung von somatostatin. | |
| TR199800850T2 (xx) | Kan� d�zenleyici bile�imler. | |
| FR2758558B1 (fr) | Nouveaux derives de la 1,4-dihydropyridine et leur utilisation en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0858345 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |